Lower levels of ACE2 protein in placentas from COVID-19 positive pregnancies have also been reported [22], hinting that SARS-CoV-2 infection may directly or indirectly change ACE2 expression and biological functions in the placenta as well as in maternal and fetal circulations. This evidence concerns the gene ACE2 and COVID-19.